PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.00p | +1.48% | 68.50p | 67.00p | 70.00p | 68.50p | 67.00p | 67.50p | 129,466 | 15:04:19 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Support Services | 0.6 | -8.9 | -10.1 | - | 98.29 |
Angle (AGL) News Headlines
Angle News
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/4/2019 | 12:29 | ALNC |  Angle's Parsortix System Used In Further "Groundbreaking" Research |
| 26/4/2019 | 07:01 | UKREG | Angle PLC IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS |
| 18/4/2019 | 11:35 | ALNC | US Cancer Centre Uses Angle's Parsortix System For Assessments |
| 18/4/2019 | 07:19 | ALNC | *Angle Says Parsortix Used To Develop New Technique For Assessing Cancer |
| 18/4/2019 | 07:00 | RNSNON | Angle PLC Parsortix used in new cancer assessment technique |
| 12/4/2019 | 11:59 | ALNC | University Of Athens Cancer Study To Use Angle's Parsortix System |
| 12/4/2019 | 07:00 | RNSNON | Angle PLC LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM |
| 04/4/2019 | 07:01 | UKREG | Angle PLC AACR 2019 |
| 07/3/2019 | 13:09 | ALNC | Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix |
| 07/3/2019 | 07:01 | UKREG | Angle PLC ENROLMENT COMPLETE FOR FDA CLINICAL STUDY |
1 Year Angle Chart |
Intraday Angle Chart |
